See more : Ruchira Papers Limited (RUCHIRA.BO) Income Statement Analysis – Financial Results
Complete financial analysis of TPCO Holding Corp. (GRAMF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TPCO Holding Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Zoono Group Limited (ZNO.AX) Income Statement Analysis – Financial Results
- Ono Pharmaceutical Co., Ltd. (OPHLY) Income Statement Analysis – Financial Results
- Keywords Studios plc (KYYWF) Income Statement Analysis – Financial Results
- Beijing Enterprises Water Group Limited (BJWTY) Income Statement Analysis – Financial Results
- Generation Asia I Acquisition Limited (GAQ) Income Statement Analysis – Financial Results
TPCO Holding Corp. (GRAMF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.theparent.co
About TPCO Holding Corp.
TPCO Holding Corp., cultivates, extracts, manufactures, distributes, retails, and delivers cannabis in California. The company offers approximately 17 owned and licensed brands offering 250 stock keeping units across form-factors, such as jarred and bagged whole flower, pre-rolls, infused pre-rolls, bulk extracts, vaporizer cartridges, ready-to-use vapes, concentrates, gummies, chocolate, capsules, tinctures, topicals, and body care products. As of December 31, 2021, the Company operated eleven retail locations and six consumer delivery hubs; and four stores under the Caliva, Deli by Caliva, Coastal, and Calma brands, as well as through Caliva.com, a direct-to-consumer e-commerce platform. The company was formerly known as Subversive Capital Acquisition Corp. and changed its name to TPCO Holding Corp. in January 2021. TPCO Holding Corp. was incorporated in 2019 and is headquartered in San Jose, California.
| Metric | 2022 | 2021 | 2020 |
|---|---|---|---|
| Revenue | 83.64M | 173.41M | 2.35M |
| Cost of Revenue | 57.63M | 153.18M | 0.00 |
| Gross Profit | 26.01M | 20.23M | 2.35M |
| Gross Profit Ratio | 31.10% | 11.67% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 95.69M | 109.57M | 8.81M |
| Selling & Marketing | 12.68M | 42.57M | 0.00 |
| SG&A | 108.37M | 152.14M | 8.81M |
| Other Expenses | 30.01M | 32.29M | 0.00 |
| Operating Expenses | 138.38M | 184.43M | 8.81M |
| Cost & Expenses | 196.01M | 337.62M | 8.81M |
| Interest Income | 845.86K | 1.24M | 2.35M |
| Interest Expense | 4.93M | 5.18M | 2.35M |
| Depreciation & Amortization | 28.03M | 27.62M | 206.30K |
| EBITDA | -84.34M | 98.05M | -38.02M |
| EBITDA Ratio | -100.84% | 56.54% | -1,617.64% |
| Operating Income | -112.37M | 70.44M | -38.02M |
| Operating Income Ratio | -134.36% | 40.62% | -1,617.64% |
| Total Other Income/Expenses | -140.30M | 229.11M | -2.35M |
| Income Before Tax | -252.67M | -589.40M | -40.37M |
| Income Before Tax Ratio | -302.10% | -339.88% | -1,717.64% |
| Income Tax Expense | -14.97M | -2.37M | 2.35M |
| Net Income | -237.70M | -587.03M | -42.72M |
| Net Income Ratio | -284.20% | -338.51% | -1,817.64% |
| EPS | -2.32 | -6.18 | -2.81 |
| EPS Diluted | -2.32 | -6.18 | -2.81 |
| Weighted Avg Shares Out | 102.63M | 95.01M | 15.22M |
| Weighted Avg Shares Out (Dil) | 102.63M | 95.01M | 15.22M |
Best Marijuana Stocks To Buy Now? 3 To Watch Today
Top US Marijuana Stocks Under $2 For April 2023
2 Marijuana Stocks To Watch This Week For Better Momentum
Best Marijuana Stocks Under $1 For April 2023
Top Marijuana Penny Stocks For April 2023
3 Top Marijuana Stocks That Are For Cannabis Investors
Best Marijuana Stocks To Buy? 3 Penny Stocks To Watch Next Week
Top Marijuana Penny Stocks With The Best Year To Date Performance In 2023
Cannabis Consolidation Continues
Top US Marijuana Penny Stocks Under $1? 3 To Watch The End Of January
Source: https://incomestatements.info
Category: Stock Reports